Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

1.

Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: A prospective analysis.

A M Heemskerk-Gerritsen B, Rookus MA, Aalfs CM, Ausems MG, Collée JM, Jansen L, Kets CM, Keymeulen KB, Koppert LB, Meijers-Heijboer HE, Mooij TM, Tollenaar RA, Vasen HF, Hebon, Hooning MJ, Seynaeve C.

Int J Cancer. 2014 Jun 20. doi: 10.1002/ijc.29032. [Epub ahead of print]

PMID:
24947112
[PubMed - as supplied by publisher]
2.

Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium.

Milne RL, Burwinkel B, Michailidou K, Arias-Perez JI, Zamora MP, Menéndez-Rodríguez P, Hardisson D, Mendiola M, González-Neira A, Pita G, Alonso MR, Dennis J, Wang Q, Bolla MK, Swerdlow A, Ashworth A, Orr N, Schoemaker M, Ko YD, Brauch H, Hamann U; The GENICA Network, Andrulis IL, Knight JA, Glendon G, Tchatchou S, Investigators K; Australian Ovarian Cancer Study Group, Matsuo K, Ito H, Iwata H, Tajima K, Li J, Brand JS, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Lambrechts D, Peuteman G, Christiaens MR, Smeets A, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Hartman M, Hui M, Lim WY, Chan CW, Marme F, Yang R, Bugert P, Lindblom A, Margolin S, García-Closas M, Chanock SJ, Lissowska J, Figueroa JD, Bojesen SE, Nordestgaard BG, Flyger H, Hooning MJ, Kriege M, van den Ouweland AM, Koppert LB, Fletcher O, Johnson N, Dos-Santos-Silva I, Peto J, Zheng W, Deming-Halverson S, Shrubsole MJ, Long J, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Cox A, Cross SS, Reed MW, Schmidt MK, Broeks A, Cornelissen S, Braaf L, Kang D, Choi JY, Park SK, Noh DY, Simard J, Dumont M, Goldberg MS, Labrèche F, Fasching PA, Hein A, Ekici AB, Beckmann MW, Radice P, Peterlongo P, Azzollini J, Barile M, Sawyer E, Tomlinson I, Kerin M, Miller N, Hopper JL, Schmidt DF, Makalic E, Southey MC, Teo SH, Yip CH, Sivanandan K, Tay WT, Shen CY, Hsiung CN, Yu JC, Hou MF, Guénel P, Truong T, Sanchez M, Mulot C, Blot W, Cai Q, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Bogdanova N, Dörk T, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Shu XO, Lu W, Gao YT, Zhang B, Couch FJ, Toland AE; TNBCC, Yannoukakos D, Sangrajrang S, McKay J, Wang X, Olson JE, Vachon C, Purrington K, Severi G, Baglietto L, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Devilee P, Tollenaar RA, Seynaeve C, Czene K, Eriksson M, Humphreys K, Darabi H, Ahmed S, Shah M, Pharoah PD, Hall P, Giles GG, Benítez J, Dunning AM, Chenevix-Trench G, Easton DF.

Hum Mol Genet. 2014 Jun 18. pii: ddu311. [Epub ahead of print]

PMID:
24943594
[PubMed - as supplied by publisher]
Free Article
3.

Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: A national cohort study.

Saadatmand S, Vos JR, Hooning MJ, Oosterwijk JC, Koppert LB, de Bock GH, Ausems MG, van Asperen CJ, Aalfs CM, Gómez Garcia EB, Meijers-Heijboer H, Hoogerbrugge N, Piek M, Seynaeve C, Verhoef C, Rookus M, Tilanus-Linthorst MM; the Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON).

Int J Cancer. 2014 May 2. doi: 10.1002/ijc.28941. [Epub ahead of print]

PMID:
24789418
[PubMed - as supplied by publisher]
4.

Prophylactic nipple-sparing mastectomy leaves more terminal duct lobular units in situ as compared with skin-sparing mastectomy.

van Verschuer VM, van Deurzen CH, Westenend PJ, Rothbarth J, Verhoef C, Luiten EJ, Menke-Pluijmers MB, Koppert LB.

Am J Surg Pathol. 2014 May;38(5):706-12. doi: 10.1097/PAS.0000000000000180.

PMID:
24698963
[PubMed - indexed for MEDLINE]
5.

Lower mitotic activity in BRCA1/2-associated primary breast cancers occurring after risk-reducing salpingo-oophorectomy.

van Verschuer VM, Heemskerk-Gerritsen BA, van Deurzen CH, Obdeijn IM, Tilanus-Linthorst MM, Verhoef C, Schmidt MK, Koppert LB, Hooning MJ, Seynaeve C.

Cancer Biol Ther. 2014 Apr;15(4):371-9. doi: 10.4161/cbt.27628. Epub 2014 Jan 14.

PMID:
24423863
[PubMed - in process]
6.

[Choices for women at risk of hereditary breast cancer].

Saadatmand S, Obdeijn IM, Koppert LB, Tilanus-Linthorst M.

Ned Tijdschr Geneeskd. 2013;157(43):A6625. Dutch.

PMID:
24152366
[PubMed - indexed for MEDLINE]
7.

Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis.

Heemskerk-Gerritsen BA, Menke-Pluijmers MB, Jager A, Tilanus-Linthorst MM, Koppert LB, Obdeijn IM, van Deurzen CH, Collée JM, Seynaeve C, Hooning MJ.

Ann Oncol. 2013 Aug;24(8):2029-35. doi: 10.1093/annonc/mdt134. Epub 2013 Apr 10.

PMID:
23576707
[PubMed - indexed for MEDLINE]
Free Article
8.

Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer.

Koppert LB, Lemmens VE, Coebergh JW, Steyerberg EW, Wijnhoven BP, Tilanus HW, Janssen-Heijnen ML.

Br J Surg. 2012 Dec;99(12):1693-700. doi: 10.1002/bjs.8952.

PMID:
23132417
[PubMed - indexed for MEDLINE]
9.

Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial.

Saadatmand S, Rutgers EJ, Tollenaar RA, Zonderland HM, Ausems MG, Keymeulen KB, Schlooz-Vries MS, Koppert LB, Heijnsdijk EA, Seynaeve C, Verhoef C, Oosterwijk JC, Obdeijn IM, de Koning HJ, Tilanus-Linthorst MM.

BMC Cancer. 2012 Oct 2;12:440. doi: 10.1186/1471-2407-12-440.

PMID:
23031619
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Sternal resection for sarcoma, recurrent breast cancer, and radiation-induced necrosis.

Koppert LB, van Geel AN, Lans TE, van der Pol C, van Coevorden F, Wouters MW.

Ann Thorac Surg. 2010 Oct;90(4):1102-1108.e2. doi: 10.1016/j.athoracsur.2010.06.044.

PMID:
20868795
[PubMed - indexed for MEDLINE]
11.

Outcome of esophagectomy for cancer in elderly patients.

Cijs TM, Verhoef C, Steyerberg EW, Koppert LB, Tran TC, Wijnhoven BP, Tilanus HW, de Jonge J.

Ann Thorac Surg. 2010 Sep;90(3):900-7. doi: 10.1016/j.athoracsur.2010.05.039.

PMID:
20732515
[PubMed - indexed for MEDLINE]
12.

Chemotherapy followed by surgery in patients with carcinoma of the distal esophagus and celiac lymph node involvement.

Boonstra JJ, Koppert LB, Wijnhoven BP, Tilanus HW, Van Dekken H, Tran TC, Van der Gaast A.

J Surg Oncol. 2009 Oct 1;100(5):407-13. doi: 10.1002/jso.21358.

PMID:
19653239
[PubMed - indexed for MEDLINE]
13.

Molecular biological challenges in he treatment of esophageal adenocarcinoma.

Boonstra JJ, Dinjens WN, Tilanus HW, Koppert LB.

Expert Rev Gastroenterol Hepatol. 2007 Dec;1(2):275-86. doi: 10.1586/17474124.1.2.275. Review.

PMID:
19072420
[PubMed - indexed for MEDLINE]
14.

Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS).

van Heijl M, van Lanschot JJ, Koppert LB, van Berge Henegouwen MI, Muller K, Steyerberg EW, van Dekken H, Wijnhoven BP, Tilanus HW, Richel DJ, Busch OR, Bartelsman JF, Koning CC, Offerhaus GJ, van der Gaast A.

BMC Surg. 2008 Nov 26;8:21. doi: 10.1186/1471-2482-8-21.

PMID:
19036143
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Laparoscopic correction of umbilical hernias using a transabdominal preperitoneal approach: results of a pilot study.

Hilling DE, Koppert LB, Keijzer R, Stassen LP, Oei IH.

Surg Endosc. 2009 Aug;23(8):1740-4. doi: 10.1007/s00464-008-0177-5. Epub 2008 Nov 18.

PMID:
19015918
[PubMed - indexed for MEDLINE]
16.

Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score.

Steyerberg EW, Neville BA, Koppert LB, Lemmens VE, Tilanus HW, Coebergh JW, Weeks JC, Earle CC.

J Clin Oncol. 2006 Sep 10;24(26):4277-84.

PMID:
16963730
[PubMed - indexed for MEDLINE]
Free Article
17.

Identification of a 7.1-mega base pairs minimal deletion at 14q31.1-32.11 in adenocarcinomas of the gastroesophageal junction.

Dinjens WN, Koppert LB, Dezentjé DA, Abbou M, van Ballegooijen ES, Sleddens HF, van Dekken H, Tilanus HW, Wijnhoven BP.

Hum Pathol. 2006 May;37(5):534-41. Epub 2006 Mar 20.

PMID:
16647950
[PubMed - indexed for MEDLINE]
18.

Regarding "3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy".

Kok NF, Koppert LB.

J Vasc Surg. 2006 Mar;43(3):643-4; author reply 644. No abstract available.

PMID:
16520193
[PubMed - indexed for MEDLINE]
Free Article
19.

Genomic analysis of early adenocarcinoma of the esophagus or gastroesophageal junction: tumor progression is associated with alteration of 1q and 8p sequences.

van Dekken H, Wink JC, Vissers KJ, van Marion R, Koppert LB, Tilanus HW, Siersema PD, Tanke HJ, Szuhai K, Hop WC.

Genes Chromosomes Cancer. 2006 May;45(5):516-25.

PMID:
16479570
[PubMed - indexed for MEDLINE]
20.

The molecular biology of esophageal adenocarcinoma.

Koppert LB, Wijnhoven BP, van Dekken H, Tilanus HW, Dinjens WN.

J Surg Oncol. 2005 Dec 1;92(3):169-90. Review.

PMID:
16299787
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk